Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?

A. de Roux, A. Rano, E. Garcia, M. A. Marcos, I. Aldabo, J. Puig de la Bellacasa, J. Mensa, A. Torres (Barcelona, Spain)

Source: Annual Congress 2003 - Acute exacerbations of COPD
Session: Acute exacerbations of COPD
Session type: Thematic Poster Session
Number: 2133
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. de Roux, A. Rano, E. Garcia, M. A. Marcos, I. Aldabo, J. Puig de la Bellacasa, J. Mensa, A. Torres (Barcelona, Spain). Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?. Eur Respir J 2003; 22: Suppl. 45, 2133

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Community-acquired pneumonia (CAP) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015



Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 55s
Year: 2005

Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012



Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006



Patient’s knowledge about risk factors for acute exacerbation( AE ) of chronic obstructive pulmonary disease( COPD )
Source: Eur Respir J 2004; 24: Suppl. 48, 514s
Year: 2004

7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001

The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 277s
Year: 2002

The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014


Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection?
Source: Eur Respir J 2001; 18: Suppl. 33, 172s
Year: 2001